ROYAL BANK OF CANADA - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 27 filers reported holding ARCA BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q2 2024$033
-41.1%
0.00%
Q1 2024$0560.0%0.00%
Q4 2023$056
-11.1%
0.00%
Q3 2023$0
-100.0%
63
-75.6%
0.00%
Q2 2023$1,0002580.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 500,000$1,030,0000.23%
SG3 Management, LLC 200,000$412,0000.03%
Marquette Asset Management, LLC 17,318$36,0000.01%
SG3 Management, LLC 75,412$155,6740.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$97,0000.00%
Tekla Capital Management LLC 32,461$67,0000.00%
Virtu Financial LLC 14,221$29,0000.00%
GROUP ONE TRADING, L.P. 144,284$297,0000.00%
WELLS FARGO & COMPANY/MN 96$00.00%
NORTHERN TRUST CORP 17,517$36,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders